Carrefour: H1 Performance and H2 Expectations
Finance

Carrefour: H1 Performance and H2 Expectations

authorBy David Rubenstein
DateJul 27, 2026
Read time2 min
This article provides an in-depth look into Carrefour's first-half 2026 performance, highlighting strengths in core markets alongside challenges in recent acquisitions. It explores the financial details and strategic implications, offering insights into what the second half of the year might hold for the retail giant.

Carrefour's H2: The Decisive Half for Future Valuation

Carrefour's H1 2026 Performance: A Mixed Picture

Carrefour SA has received a 'hold' rating due to a performance that presented both positive and negative aspects in the first half of 2026. While key markets like France, Spain, and Brazil demonstrated solid growth in recurring operating income and improved profit margins, the overall group's profitability and free cash flow experienced a downturn when excluding the contributions from Italy and Romania. This dichotomy suggests a need for a more balanced assessment of the company's financial health.

The Challenge of Cora & Match: Aiming for Breakeven

A significant area of concern remains the performance of Cora & Match. These entities continued to operate at a loss, with the company setting a target for them to reach breakeven by the fiscal year 2026. Achieving this goal is paramount, as a strong conversion of profits in the second half of the year is essential not only for improving financial metrics but also for boosting investor confidence and enhancing the company's valuation.

Navigating Free Cash Flow Targets: The Importance of Organic Growth

To meet its free cash flow guidance for fiscal year 2026, Carrefour is heavily reliant on a substantial contribution from the second half. Investors will be closely watching to see if this can be achieved through organic operational improvements rather than through non-recurring measures such as sale-and-leaseback transactions. A dependence on asset sales to meet cash flow targets would likely be perceived negatively by the market, potentially hindering long-term growth prospects and investor appeal.

More Articles
Finance
Adamas Mortgage REIT: Analyzing Baby Bonds for Stability
This analysis focuses on Adamas, a mortgage REIT, and its baby bonds. While the common equity of Adamas is rated 'Hold' due to its mixed historical performance and exposure to various risks, its publicly traded notes present a more appealing fixed-income opportunity. These notes offer attractive yields and shorter maturities, supported by adequate interest coverage and a substantial equity cushion. This suggests a safer investment avenue for those prioritizing stability over high growth.
By Nouriel RoubiniJul 27, 2026
Finance
GoodHaven Fund's Semi-Annual Performance and Investment Outlook
GoodHaven Fund's latest semi-annual report reveals a period of underperformance relative to the S&P 500, with a focus on long-term investment strategies amidst market volatility. The fund discusses key contributors and detractors, portfolio adjustments, and their optimistic outlook on undervalued sectors like housing and specific companies such as Asbury Automotive, despite broader economic uncertainties.
By Strive MasiyiwaJul 27, 2026
Finance
OPEC's July 2026 Oil Market Report Reveals Output Surge Amidst Falling Global Demand
OPEC nations significantly boosted crude oil production in June 2026, primarily led by the UAE, Kuwait, Iraq, and Iran. This surge comes as global crude oil demand experienced a notable decline between Q2 2025 and Q2 2026. The latest report has prompted a downward revision of the 2026 annual liquid fuel demand forecast, raising questions about market stability amidst evolving supply and demand dynamics.
By Suze OrmanJul 27, 2026
Finance
Popular, Inc.: A Robust Investment in a Rising Interest Rate Environment
Popular, Inc. (BPOP) presents a compelling investment opportunity, particularly for those seeking diversification away from AI-exposed equities. The company is strategically positioned to thrive in a high-interest-rate environment, boasting a dominant market presence in Puerto Rico and consistently strong financial performance. With impressive net margins, return on common equity, and a robust CET1 capital ratio, BPOP not only sustains growth but also delivers substantial shareholder returns through dividends and share buybacks. Its attractive valuation, below the sector median for P/E, coupled with superior EPS and ROE growth, solidifies its appeal.
By Michele FerreroJul 27, 2026
Finance
Veradermics: Pioneer in Pattern Hair Loss Treatment with Promising Oral Minoxidil
Veradermics, a clinical biotech firm, is advancing VDPHL01, a groundbreaking non-hormonal oral minoxidil for pattern hair loss. This innovative treatment has demonstrated significant efficacy and safety in Phase 2/3 trials, exceeding expectations and positioning the company as a potential leader in the hair regrowth market. With robust financial backing and a clear path to FDA submission and commercial launch, Veradermics is poised for substantial impact, though investors should consider a 'Hold' rating until the imminent IPO lockup expiration passes.
By David RubensteinJul 27, 2026